Keyphrases
Monoclonal Antibody
100%
Islet Allograft
100%
Anti-CD40
100%
Allograft Survival
100%
LEA29Y
100%
Synergize
100%
T Cell Activation
50%
CD154
50%
Clinical Trials
25%
Belatacept
25%
Clinical Application
25%
Islet Transplantation
25%
CD40
25%
CD28
25%
High Affinity
25%
Rodents
25%
Antiviral Immunity
25%
Partial Agonist
25%
Possible Complications
25%
Long-term Survival
25%
CD80
25%
Islet Survival
25%
Targeting Signal
25%
Nonhuman Primate Model
25%
Anti-CD154
25%
CD20
25%
CD40/CD154
25%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
25%
Combined Therapy
25%
Rationally Designed
25%
Immunology and Microbiology
Monoclonal Antibody
100%
CD154
100%
Allograft
100%
Islet Transplantation
25%
T Cell Activation
25%
Antiviral Immunity
25%
Cell Function
25%
Agonist
25%
CD28
25%
CD20
25%
CD80
25%
Long Term Survival
25%
Abatacept
25%
Belatacept
25%